Cartesian Therapeutics, Inc.
RNAC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $143 | $160 | $180 | $213 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $0 | $2 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $3 | $3 |
| Total Curr. Assets | $147 | $163 | $185 | $217 |
| Property Plant & Equip (Net) | $17 | $17 | $16 | $15 |
| Goodwill | $48 | $48 | $48 | $48 |
| Intangibles | $151 | $151 | $151 | $151 |
| Long-Term Investments | $2 | $2 | $2 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $7 | $8 | $2 |
| Total NC Assets | $225 | $225 | $224 | $218 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $373 | $389 | $409 | $435 |
| Liabilities | – | – | – | – |
| Payables | $2 | $0 | $2 | $0 |
| Short-Term Debt | $4 | $4 | $4 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $8 | $9 | $20 |
| Total Curr. Liab. | $14 | $12 | $15 | $23 |
| LT Debt | $9 | $10 | $10 | $11 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $16 | $0 | $0 |
| Other NC Liab. | $386 | $353 | $406 | $408 |
| Total NC Liab. | $395 | $379 | $416 | $419 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13 | $13 | $14 | $14 |
| Total Liabilities | $409 | $391 | $431 | $442 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$730 | -$694 | -$710 | -$692 |
| AOCI | -$5 | -$5 | -$5 | -$5 |
| Other Equity | $699 | $696 | $693 | $690 |
| Total Equity | -$36 | -$3 | -$22 | -$7 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $373 | $389 | $409 | $435 |
| Net Debt | -$131 | -$147 | -$166 | -$199 |